Skip to content

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Efficacy and safety analysis of consolidation immunotherapy following definitive concurrent chemoradiotherapy for locally advanced esophageal squamous cell carcinoma

Background Definitive concurrent chemoradiotherapy (dCRT) is standard for locally advanced esophageal squamous cell carcinoma (ESCC), but recurrences remain common. Evidence for consolidation immunotherapy after dCRT is limited. This study evaluated the efficacy and safety of consolidation immunotherapy after dCRT and...

Wan-Ming Liu, Qian Zhu, Si-Yuan Xu et al. · 0 citations
Open access Sep 2026

TET1 loss promotes malignant phenotypes in HeLa cells and is associated with altered PTEN–PI3K/AKT/mTOR signaling

Reduced TET1 expression was observed in SCC-restricted public cohorts, while TET1 depletion promoted malignant phenotypes in HeLa cells, which identifies a candidate signaling association that warrants validation through rescue experiments and locus-specific epigenetic studies.

Yan Liu, Lu-Jia Liu, Lu-Sheng Wang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.